Galway company behind the PerQseal family of fully absorbable patch implants that close large bore arterial access sites. Haemonetics acquired it in January 2026 in a deal worth up to 185 million euros.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.